bioAffinity Technologies, Inc. Repayments of Short-term Debt
bioAffinity Technologies, Inc. (BIAF) reported Repayments of Short-term Debt of $87.45 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-08-07
- bioAffinity Technologies, Inc. repayments of short-term debt for the quarter ending 2026-06-30 was $46.11K, a 37.71% decline year-over-year.
- bioAffinity Technologies, Inc. repayments of short-term debt for the quarter ending 2026-03-31 was $41.34K, a 6.20% increase year-over-year.
- bioAffinity Technologies, Inc. repayments of short-term debt for the quarter ending 2025-09-30 was -$101.16K.
- bioAffinity Technologies, Inc. repayments of short-term debt for the quarter ending 2025-06-30 was $74.02K.
- bioAffinity Technologies, Inc. repayments of short-term debt for fiscal 2023 was $251.75K.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $46.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $87.45K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $41.34K 10-Q · filed 2026-05-11 | |||
| 2025-09-30 | -$101.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$27.13K derived: sum of 2 quarters · filed 2026-08-07 | $11.79K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $74.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $112.95K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | $38.93K 10-Q · filed 2026-05-11 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $42.33K derived: sum of 2 quarters · filed 2025-03-31 | $168.43K derived: sum of 3 quarters · filed 2025-03-31 | $251.75K 10-K · filed 2025-03-31 |
| 2023-09-30 | $42.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $168.43K derived: sum of 2 quarters · filed 2024-11-14 | $251.75K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $126.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $209.41K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $83.32K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |